As of 3:26pm ET
| 0.00 / 0.00%|
The 7 analysts offering 12-month price forecasts for Bellicum Pharmaceuticals Inc have a median target of 19.00, with a high estimate of 23.00 and a low estimate of 14.00. The median estimate represents a +149.34% increase from the last price of 7.62.
The current consensus among 7 polled investment analysts is to Buy stock in Bellicum Pharmaceuticals Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.